Spots Global Cancer Trial Database for A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
Official Title: A Phase III, Open-Label, Randomized Study of On-Demand TACE Combined With Atezolizumab Plus Bevacizumab (Atezo/Bev) or On-Demand TACE Alone in Patients With Untreated Heaptocellular Carcionma
Study ID: NCT04712643
Conditions
Study Description
Brief Summary: This study will evaluate the efficacy and safety of atezolizumab plus bevacizumab combined with on-demand TACE compared to on-demand TACE alone in participants with hepatocellular carcinoma who are at high risk of poorer outcome following TACE treatment.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Peking University First Hospital, Beijing City, , China
Beijing You An Hospital; Digestive Dept, Beijing City, , China
Beijing Tsinghua Changgung Hospital, Beijing City, , China
Peking University People's Hospital, Beijing, , China
Hunan Cancer Hospital, Changsha CITY, , China
Sichuan Cancer Hospital, Chengdu City, , China
West China Hospital, Sichuan University; Surgical Oncology, Chengdu City, , China
The First Affiliated Hospital, Chongqing Medical University, Chongqing, , China
Southwest Hospital , Third Military Medical University, Chongqing, , China
The First Affiliated Hospital Of Fujian Medical University, Fuzhou City, , China
Mengchao Hepatobiliary Hospital Of Fujian Medical University, Fuzhou City, , China
The 900th Hospital of PLA joint service support force, Fuzhou, , China
Fujian Cancer Hospital, Fuzhou, , China
The First Affiliated Hospital of Sun Yat-sen University, Guangzhou City, , China
Sun Yet-sen University Cancer Center, Guangzhou City, , China
Nanfang Hospital, Southern Medical University, Guangzhou, , China
Harbin Medical University Cancer Hospital; internal medicine, Harbin City, , China
Anhui Provincial Hospital, Hefei, , China
Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University), Nanjing City, , China
Jiangsu Cancer Hospital, Nanjing City, , China
Guangxi Cancer Hospital of Guangxi Medical University, Nanning City, , China
The First Affiliate Hospital of Guangxi Medical University, Nanning, , China
Zhongshan Hospital Fudan Unvierstiy, Shanghai City, , China
Fudan University Shanghai Cancer Center, Shanghai City, , China
Renji Hospital Shanghai Jiaotong University School of Medicine, Shanghai City, , China
Shengjing Hospital of China Medical University, ShenYang, , China
Tianjin Cancer Hospital; Surgical Department, Tianjin City, , China
The First Affiliated Hospital of Xi'an Jiaotong University; Hepatobiliary surgery Department, Xi'an, , China
Xi'an Inernational Medical Center Hospital, Xi'an, , China
Zhejiang Cancer Hospital, Zhejiang, , China
Henan Cancer Hospital, Zhengzhou, , China
Zhuhai People's Hospital, Zhuhai, , China
Aichi Cancer Center, Aichi, , Japan
Chiba University Hospital, Chiba, , Japan
Kurume University Hospital, Fukuoka, , Japan
Hiroshima University Hospital, Hiroshima, , Japan
Yokohama City University Medical Center, Kanagawa, , Japan
Kanagawa Cancer Center, Kanagawa, , Japan
Kitasato University Hospital, Kanagawa, , Japan
Osaka University Hospital, Osaka, , Japan
Kindai University Hospital, Osaka, , Japan
Toranomon Hospital, Tokyo, , Japan
Contact Details
Name: Clinical Trials
Affiliation: Hoffmann-La Roche
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
